VIMIAN GROUP AB |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 34.7 SEK | +0.14% |
|
+2.21% | +17.23% |
| 02/05 | Transcript : Vimian Group AB, Q1 2024 Earnings Call, May 02, 2024 | |
| 02/05 | Vimian Group AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Presentation Operator MessageOperator (Operator)Welcome to the Vimian Group Q1 2024. [Operator...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
Vimian Group AB is a Sweden-based veterinary company. The Company is a parent company of the group of companies operating with a purpose of improving animal health through science and technology. The Group delivers solutions to veterinary professionals, labs and pet parents around the world. The purpose of Vimian Group is to unite companies in selected niches of animal health and help them grow faster. The Company invests in innovation and new technologies to advance veterinary medicine. The Group covers four essential and rapidly evolving areas within animal health: Specialty Pharma, Diagnostics, Veterinary Services and MedTech. Vimian provides individual businesses with access to its networks, advisory services, infrastructure and capital.
Sector
Pharmaceuticals
Calendar
22/05/2024
- Annual General Meeting
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
6
Last Close Price
2.979
EUR
Average target price
3.372
EUR
Spread / Average Target
+13.21%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +17.23% | 1.69B | |
| -11.98% | 79.26B | |
| +25.75% | 3.74B | |
| -0.83% | 3.27B | |
| -6.22% | 1.56B | |
| -23.36% | 1.29B | |
| -1.76% | 1.28B | |
| -12.76% | 1.14B | |
| +0.79% | 1.06B | |
| -6.98% | 1.01B |
- Stock Market
- Equities
- VIMIAN Stock
- News Vimian Group AB
- Transcript : Vimian Group AB, Q1 2024 Earnings Call, May 02, 2024
